Mitsubishi UFJ Morgan Stanley Securities’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-70
Closed -$7K – 63
2022
Q4
$7K Buy
70
+10
+17% +$965 0.06% 133
2022
Q3
$6K Hold
60
– – 0.08% 129
2022
Q2
$6K Hold
60
– – 0.01% 133
2022
Q1
$6K Sell
60
-150
-71% -$15.8K 0.01% 143
2021
Q4
$22K Buy
+210
New +$19.4K 0.01% 125
2014
Q4
$54K Hold
560
– – 0.11% 47
2014
Q3
$45K Buy
560
+100
+22% +$7.88K 0.13% 62
2014
Q2
$35K Sell
460
-220
-32% -$16.6K 0.1% 73
2014
Q1
$51K Buy
680
+150
+28% +$10.6K 0.14% 49
2013
Q4
$38K Hold
530
– – 0.06% 86
2013
Q3
$30K Buy
+530
New +$31.6K 0.05% 143

Other funds holding CVS

Mitsubishi UFJ Morgan Stanley Securities's CVS Position: Q1 2023 in Review

Mitsubishi UFJ Morgan Stanley Securities sold out of CVS Health (CVS) in Q1 2023, closing a stake of 70 shares — an estimated $7K sold.

Mitsubishi UFJ Morgan Stanley Securities first reported a position in CVS in Q3 2013 and held it in 11 quarters. The position peaked at $54K in Q4 2014. 2,270 funds tracked by Wall St. Rank hold CVS as of Q1 2023.

  • Mitsubishi UFJ Morgan Stanley Securities reported no remaining CVS Health position as of Q1 2023 after selling out during the quarter.
  • Mitsubishi UFJ Morgan Stanley Securities sold 70 CVS Health shares in Q1 2023, an estimated $7K.
  • Mitsubishi UFJ Morgan Stanley Securities first reported a position in CVS Health in Q3 2013 and held it in 11 quarters.
  • Mitsubishi UFJ Morgan Stanley Securities's CVS Health position peaked at $54K in Q4 2014.
  • 2,270 funds tracked by Wall St. Rank held CVS Health as of Q1 2023.

Based on Mitsubishi UFJ Morgan Stanley Securities's 13F filing for Q1 2023, filed 2 May 2023.